Segall Bryant & Hamill’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-118,161
| Closed | -$9.94M | – | 606 |
|
|
2025
Q2 | $9.94M | Buy |
118,161
+20,220
| +21% | +$1.77M | 0.14% | 234 |
|
|
2025
Q1 | $9.28M | Sell |
97,941
-2,734
| -3% | -$289K | 0.14% | 227 |
|
|
2024
Q4 | $11.1M | Buy |
100,675
+15,925
| +19% | +$1.82M | 0.15% | 209 |
|
|
2024
Q3 | $9.58M | Sell |
84,750
-3,458
| -4% | -$403K | 0.13% | 237 |
|
|
2024
Q2 | $10.9M | Buy |
88,208
+2,387
| +3% | +$299K | 0.19% | 171 |
|
|
2024
Q1 | $11.1M | Sell |
85,821
-1,222
| -1% | -$148K | 0.21% | 167 |
|
|
2023
Q4 | $10.7M | Sell |
87,043
-865
| -1% | -$92.1K | 0.21% | 173 |
|
|
2023
Q3 | $8.98M | Sell |
87,908
-545
| -0.6% | -$56.9K | 0.1% | 227 |
|
|
2023
Q2 | $8.88M | Buy |
88,453
+420
| +0.5% | +$42.1K | 0.09% | 254 |
|
|
2023
Q1 | $9.04M | Buy |
88,033
+1,088
| +1% | +$117K | 0.1% | 242 |
|
|
2022
Q4 | $8.94M | Buy |
86,945
+17,843
| +26% | +$1.81M | 0.1% | 237 |
|
|
2022
Q3 | $5.92M | Buy |
69,102
+17,685
| +34% | +$1.67M | 0.07% | 281 |
|
|
2022
Q2 | $4.92M | Buy |
51,417
+14,863
| +41% | +$1.44M | 0.06% | 317 |
|
|
2022
Q1 | $3.38M | Buy |
36,554
+91
| +0.2% | +$8.62K | 0.03% | 387 |
|
|
2021
Q4 | $3.29M | Buy |
36,463
+1,641
| +5% | +$145K | 0.03% | 375 |
|
|
2021
Q3 | $2.93M | Buy |
34,822
+894
| +3% | +$79.7K | 0.03% | 425 |
|
|
2021
Q2 | $3.07M | Sell |
33,928
-17,744
| -34% | -$1.76M | 0.03% | 421 |
|
|
2021
Q1 | $5.31M | Buy |
51,672
+19,204
| +59% | +$1.9M | 0.05% | 325 |
|
|
2020
Q4 | $2.95M | Sell |
32,468
-593
| -2% | -$46K | 0.03% | 371 |
|
|
2020
Q3 | $2.09M | Buy |
33,061
+23,180
| +235% | +$1.72M | 0.03% | 386 |
|
|
2020
Q2 | $764K | Buy |
9,881
+268
| +3% | +$19.6K | 0.01% | 497 |
|
|
2020
Q1 | $668K | Buy |
9,613
+1,462
| +18% | +$134K | 0.01% | 527 |
|
|
2019
Q4 | $843K | Sell |
8,151
-520
| -6% | -$49.7K | 0.01% | 555 |
|
|
2019
Q3 | $773K | Buy |
+8,671
| New | +$777K | 0.01% | 565 |
|
|
2016
Q4 | – | Sell |
-5,117
| Closed | -$311K | – | 551 |
|
|
2016
Q3 | $311K | Sell |
5,117
-55,648
| -92% | -$3.1M | 0.01% | 466 |
|
|
2016
Q2 | $2.79M | Sell |
60,765
-46,532
| -43% | -$2.2M | 0.07% | 255 |
|
|
2016
Q1 | $4.65M | Sell |
107,297
-196,914
| -65% | -$9.1M | 0.12% | 200 |
|
|
2015
Q4 | $16.5M | Sell |
304,211
-294,710
| -49% | -$16.3M | 0.4% | 77 |
|
|
2015
Q3 | $27.9M | Sell |
598,921
-18,724
| -3% | -$858K | 0.68% | 43 |
|
|
2015
Q2 | $27.8M | Sell |
617,645
-682
| -0.1% | -$30.6K | 0.62% | 46 |
|
|
2015
Q1 | $28.7M | Buy |
618,327
+1,294
| +0.2% | +$55.5K | 0.65% | 42 |
|
|
2014
Q4 | $26.3M | Buy |
617,033
+43,729
| +8% | +$1.79M | 0.6% | 45 |
|
|
2014
Q3 | $20.6M | Buy |
573,304
+126,667
| +28% | +$5.14M | 0.48% | 69 |
|
|
2014
Q2 | $19.3M | Sell |
446,637
-25,399
| -5% | -$1.09M | 0.46% | 69 |
|
|
2014
Q1 | $21.4M | Buy |
472,036
+19,935
| +4% | +$879K | 0.51% | 62 |
|
|
2013
Q4 | $20.9M | Sell |
452,101
-34,648
| -7% | -$1.59M | 0.49% | 65 |
|
|
2013
Q3 | $22.7M | Sell |
486,749
-19,599
| -4% | -$845K | 0.56% | 56 |
|
|
2013
Q2 | $20.3M | Buy |
+506,348
| New | +$21.1M | 0.54% | 59 |
|
Other funds holding IOSP
RA
Segall Bryant & Hamill's IOSP Position: Q3 2025 in Review
Segall Bryant & Hamill sold out of Innospec (IOSP) in Q3 2025, closing a stake of 118,161 shares — an estimated $9.94M sold.
Segall Bryant & Hamill first reported a position in IOSP in Q2 2013 and held it in 38 quarters. The position peaked at $28.7M in Q1 2015. 266 funds tracked by Wall St. Rank hold IOSP as of Q3 2025.
- Segall Bryant & Hamill reported no remaining Innospec position as of Q3 2025 after selling out during the quarter.
- Segall Bryant & Hamill sold 118,161 Innospec shares in Q3 2025, an estimated $9.94M.
- Segall Bryant & Hamill first reported a position in Innospec in Q2 2013 and held it in 38 quarters.
- Segall Bryant & Hamill's Innospec position peaked at $28.7M in Q1 2015.
- 266 funds tracked by Wall St. Rank held Innospec as of Q3 2025.
Based on Segall Bryant & Hamill's 13F filing for Q3 2025, filed 12 Nov 2025.